|
Merit Awards recognize the work of oncology fellows who are first authors of outstanding Meeting abstracts. Abstracts eligible for Merit Award consideration are evaluated during the normal abstract review period by the Scientific Program Committee, with the Pediatric Subcommittee selecting the top abstract in its category for the Brigid Leventhal Award. The monetary awards are provided by The ASCO Cancer Foundation® and are intended to aid young physicians with travel expenses for the Annual Meeting. More importantly, the award recognition supports further research in clinical oncology.
A complete list of all Merit Award recipients who will present research today follows, and includes the time and location of each session. Each edition of ASCO Daily News will include such a list.
Christina S. Baik, MD, MPH
Tufts Medical Center
“A prospective study of reproductive factors, hormone use, and risk of lung cancer in postmenopausal women” (Abstract 1501)
Oral Presentation, Cancer Prevention
3:00 PM-6:00 PM • W203C
Andrew B. Brown, MD
Memorial Sloan-Kettering Cancer Center
“Phase I study of obatoclax mesylate (GX15-070MS), a bcl-2 antagonist, plus topotecan in relapsed small cell lung carcinoma and other solid tumors” (Abstract 3504)
Clinical Science Symposium, What’s New in Apoptosis-targeting Drugs
1:15 PM-2:45 PM • Valencia Room, W415A
Windy Dean-Colomb, MD, PhD
M. D. Anderson Cancer Center
“Off-label drug use in women with breast cancer” (Abstract 1016)
Poster Discussion, Breast Cancer — Metastatic
8:00 AM-12:00 PM • W240A
Emmanuelle Godefroy, PhD
New York University
“MMP-2: A novel target for antitumor immune therapy” (Abstract 3053)
General Poster Session, Developmental Therapeutics: Immunotherapy
8:00 AM-12:00 PM • West Hall C
Yelena Y. Janjigian, MD
Memorial Sloan-Kettering Cancer Center
“Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor epidermal growth factor receptor (EGFR) mutations” (Abstract 7523
Poster Discussion, Lung Cancer — Local-regional and Adjuvant Therapy
8:00 AM-12:00 PM • W315A
Prashant Kapoor, MD
Mayo Clinc, Rochester, MN
“Prognostic value of stringent complete response (sCR) post-autologous stem cell transplant (SCT) in multiple myeloma (MM)” (Abstract 8587)
General Poster Session, Lymphoma and Plasma Cell Disorders
8:00 AM-12:00 PM • West Hall C
Ritsuko Komaki, MD
M. D. Anderson Cancer Center
“A phase II study of accelerated high-dose thoracic radiation therapy (AHTRT) with concurrent chemotherapy for limited small cell lung cancer: RTOG 02390” (Abstract 7527)
Poster Discussion, Lung Cancer — Local-regional and Adjuvant Therapy
8:00 AM-12:00 PM • W315A
Colin R. Lindsay, BSc, MBChB
Beatson Institute for Cancer Research
“Phase I dose escalation study of continuous oral dosing of OSI-906, an insulin like growth factor-1 receptor (IGF-1R) tyrosine kinase inhibitor, in patients with advanced solid tumors” (Abstract 2559)
General Poster Session, Developmental Therapeutics: Cytotoxic Chemotherapy
8:00 AM-12:00 PM • West Hall C
Nicholas Mitsiades, MD
Memorial Sloan-Kettering Cancer Center
“Increased expression of androgen receptor (AR) and enzymes involved in androgen synthesis in metastatic prostate cancer: Targets for novel personalized therapies” (Abstract 5002)
Clinical Science Symposium, Signal Transduction Pathways in Prostate Cancer
8:00 AM-9:30 AM • West Hall D1
Justin Rineer, MD
SUNY Downstate
“Utilization of radiation therapy in early-stage Hodgkin disease and its impact on survival” (Abstract 8511)
Oral Presentation, Lymphoma
1:00 PM-4:00 PM • West Hall F1
John H. Strickler, MD
Duke University Medical Center
“Integration of mRNA and microRNA profiles as prognostic and predictive markers in lung adenocarcinoma” (Abstract 7522)
Poster Discussion, Lung Cancer — Local-Regional and Adjuvant Therapy
8:00 AM-12:00 PM • W315A
Alexander C. van Akkooi, MD
Erasmus University Medical Center – Daniel den Hoed Cancer Center
“Long-term follow-up of patients with minimal sentinel node tumor burden (< 0.1mm) according to Rotterdam criteria: A study of the EORTC Melanoma Group” (Abstract 9005)
Oral Presentation, Melanoma
1:00 PM-4:15 PM • West Hall F3
Saiama N. Waqar, MBBS
Washington University in St. Louis
“Prognostic significance of tumor size in patients with stage III non-small cell lung cancer: A SEER database survey” (Abstract 7529)
Poster Discussion, Lung Cancer — Local-regional and Adjuvant Therapy
8:00 AM-12:00 PM • W315A
|
